201. New FH peptide-modified ultrasonic nanobubbles for delivery of doxorubicin to cancer-associated fibroblasts
- Author
-
Xiaoying Zhou, Mengmeng Shang, Xiao Sun, Dandan Shi, Dong Meng, Yading Zhao, Xinxin Liu, Lu Guo, and Jie Li
- Subjects
Cell Survival ,Blotting, Western ,Biomedical Engineering ,Contrast Media ,Medicine (miscellaneous) ,Bioengineering ,Peptide ,macromolecular substances ,02 engineering and technology ,Development ,03 medical and health sciences ,Drug Delivery Systems ,0302 clinical medicine ,Cancer-Associated Fibroblasts ,Cell Line, Tumor ,Tumor Microenvironment ,polycyclic compounds ,medicine ,Humans ,General Materials Science ,Doxorubicin ,Cytotoxicity ,Ultrasonography ,chemistry.chemical_classification ,Tumor microenvironment ,biology ,Tenascin C ,Tumor therapy ,021001 nanoscience & nanotechnology ,chemistry ,030220 oncology & carcinogenesis ,Cancer research ,biology.protein ,Ultrasonic sensor ,Peptides ,0210 nano-technology ,medicine.drug - Abstract
Aim: To synthesize and evaluate a novel FH peptide-modified ultrasonic nanobubble-loading doxorubicin (FH-NB-DOX) for specially cancer-associated fibroblasts (CAFs) targeting and eradication. Materials & methods: The characteristics, cytotoxicity, contrast-enhanced ultrasound imaging (CEUI), targeting ability and specially eradicating CAFs of these NBs were investigated. Results: FH-NB-DOX (about 208 nm) showed a good CEUI, and achieved higher targeting ability due to the conjunction ability of FH peptide to tenascin C protein high-level expressed in CAFs. Under ultrasound irradiation, FH-NB-DOX could delivery more DOX into CAFs, thus exhibited stronger eradication role compared with NB-DOX and free DOX. Conclusion: These new NBs, which combines the advantages of targeted theranostic agent and CEUI, is expected to be a potential approach for tumor therapy based on CAF targeting.
- Published
- 2019